Skip to main content

Couling John D's Form 4 filing

Dolby Laboratories, Inc. (DLB) · filed Feb 8, 2023

Accession no.
0001209191-23-007946
Filed
Feb 8, 2023
Trade date
Feb 6-7, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $7.34M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Couling John DCIK 0001894052Officer (SVP, Entertainment)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 6, 2023Class A Common StockMOption exerciseAcquired+50,000$37.35+$1,867,500146,245Direct
Feb 6, 2023Class A Common StockSSaleDisposed−41,738$84.48F2−$3,526,026.24104,507Direct
Feb 6, 2023Class A Common StockSSaleDisposed−8,262$85.24F3−$704,252.8896,245Direct
Feb 7, 2023Class A Common StockMOption exerciseAcquired+15,153$37.35+$565,964.55111,398Direct
Feb 7, 2023Class A Common StockMOption exerciseAcquired+21,850$45.50+$994,175133,248Direct
Feb 7, 2023Class A Common StockSSaleDisposed−31,202$83.86F4−$2,616,599.72102,046Direct
Feb 7, 2023Class A Common StockSSaleDisposed−5,801$84.37F5−$489,430.3796,245Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 6, 2023Class A Common StockMOption exerciseDisposed−50,000$0.00$015,153Direct
Feb 7, 2023Class A Common StockMOption exerciseDisposed−15,153$0.00$00Direct
Feb 7, 2023Class A Common StockMOption exerciseDisposed−21,850$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $84.03 to $85.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F3

The shares were sold in multiple transactions at prices ranging from $85.04 to $85.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $83.26 to $84.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $84.26 to $84.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

Remarks

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

Read the full filing on SEC EDGAR (opens in a new tab)